An antiviral pill to treat COVID and reduce the risk of hospitalization and death in high-risk groups could be around the corner. Here’s why immunocompromised people have the most to gain.
The COVID Vaccine Doesn't Work as Well for Immunocompromised People. Scientists are Trying To Fix That
Immunocompromised people tend not to gain the same protection from the COVID-19 vaccine as those with fully functioning immune systems. As a result, navigating the pandemic has been much more challenging for them. Meet one scientist studying this population and figuring out ways to help.